Peridot Acquisition Corp. Class A PDAC 深 沪
已收盘 08-10 16:00:00 美东时间
11.23
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 11.23
- 总市值 4.21亿
- 52周最高 125.92
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 70.48
- 委 比 0.00%
- 总股本 3750.00万
- 历史最高 125.92
- 量 比 0
- 振 幅 0.00%
- 历史最低 70.48
- 每 手 1
- 风险率 0.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多针对“癌症之王”，劲方医药宣布小分子新药获FDA快速通道资格
（来源：求实药社） 7月25日，劲方医药宣布GFH375/VS-7375（口服KRAS G12D抑制剂）获得美国FDA授予快速通道资格，用于KRAS G12D突...
07-25 12:09
Purple Biotech's Chief Executive Officer Gil Efron Issued A Letter To Shareholders Highlighting The Company's Scientific Progress, Operational Execution, And Strategic Milestones During 1H 2025
2025 First Half HighlightsCM24 (α-CEACAM1 monoclonal antibody)Our Phase 2 dataset demonstrated strong objective response rates (ORR) in biomarker-enriched subgroups of second line PDAC patients, as outlined below. These
07-24 19:29
High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 23, 2025 /PRNewswire/ -- USA News Group News Commentary – Cancer diagnoses are climbing fastest...
07-23 21:26
Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER. BC, July 16, 2025 /PRNewswire/ -- As lawmakers weigh potential cuts to scientific research funding, the ...
07-17 06:51
Otsuka’s PTSD therapy draws efficacy concerns at FDA ahead of AdCom meeting
The FDA staffers on Wednesday cited efficacy issues related to a combination regimen involving brexpiprazole, an antipsychotic medication developed by Otsuka Pharma (OTCPK:OTSKY) and H. Lundbeck (OTCP...
07-17 02:25
Amid NCI Budget Fears, Emerging Oncology Stocks Gain Attention
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 8, 2025 /PRNewswire/ -- Equity Insider News Commentary – As cancer rates climb and drug costs c...
07-08 22:25
港股医药ETF(159718)近一年上涨近70%，医疗创新ETF(516820)多只成分股飘红，机构：关注国产公司出海机遇
截至2025年7月4日10:46，中证港股通医药卫生综合指数(930965)成分股方面涨跌互现，康方生物(09926)领涨3.86%，云顶新耀(0...
07-04 10:54
Oncology Innovation Just Hit a Turning Point -- Here's What to Watch
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- USA News Group News Commentary – The oncology landscape is being pulle...
06-30 23:02
Revolution Medicines Announces FDA Breakthrough Therapy Designation For Its Daraxonrasib In Previously Treated Metastatic Pancreatic Cancer With KRAS G12 Mutations
Breakthrough Therapy Designation based on promising early clinical evidence observed with daraxonrasib in patients with pancreatic ductal adenocarcinoma (PDAC) RASolute 302, a Phase 3 registrational study of
06-23 21:01
